FDA Inspection
Teva Czech Industries s.r.o.Teva Czech Industries s.r.o. – FDA Inspection, Sep 17, 2020
Record Details
This FDA Inspection record concerns Teva Czech Industries s.r.o., with an inspection on September 17, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Teva Czech Industries s.r.o.
- Inspection Date
- September 17, 2020
- Product Type
- Drugs
View Company Profile
ID · 2925aae1-56a3-4fde-85fc-8c4d433b6118
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1152783
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Teva Czech Industries s.r.o.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 8, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 13, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 21, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Czech Industries s.r.o.
- FDA Inspection 1207600 - 2022-09-08
- FDA Inspection 1097960 - 2018-09-13
- FDA Inspection 1011464 - 2017-03-24
- FDA Inspection 876906 - 2014-03-21
- FDA Inspection 748067 - 2011-09-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.